HITACHI-HIGH-TECH
Hitachi High-Technologies Corporation (TOKYO:8036) (Hitachi High-Tech) and RIKEN, one of Japan’s national institutes for scientific research, announced today that they have jointly developed "MirrorCLEM ," a system for simplifying correlative light and electron microscopy (CLEM) which enables the observation of one using both light and scanning electron microscopes (SEM).
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160721005682/en/
MirrorCLEM will be launched for sale by Hitachi High-Tech on 25 July, 2016.
Various types of microscopes are used in a wide variety of fields such as nanotechnology, materials, medical and life sciences. In the medical and life sciences field in particular, SEMs are used to clarify the ultrastructure of cells and tissues, while a type of light microscope called fluorescence microscopes are being used increasingly to observe the localization and behavior of proteins at the molecular level. In recent years, CLEM techniques, which correlate electron microscopy with fluorescence microscopy, have been developed. However, the observation of the same field in a specimen with microscopes at different magnifications and observation characteristics remained a difficult task.
To solve this problem, in 2015 Hitachi High-Tech worked with a group led by Dr. Kiminori Toyooka, a senior research scientist with the RIKEN Center for Sustainable Resource Science, to research and develop a system for observing the ultrastructure of organelles*1 containing green fluorescent proteins (GFP)*2 . RIKEN developed the microscopic observation workflow and the preparation method of embedding in resin to preserve both the GFP fluorescence and ultrastructure. Meanwhile, Hitachi High-Tech developed a dedicated jig for observing plastic sections mounted on cover slips under a Field-Emission SEM (FE-SEM), as well as the software for swiftly and accurately observing the same location of florescence microscopy in a FE-SEM.
The MirrorCLEM system that Hitachi High-Tech and RIKEN subsequently developed supports quick and accurate CLEM analysis by using a FE-SEM. With this system, the plastic sections can be observed under a light microscope from low magnifications to magnifications that are high enough to clearly observe the structure of interest. In addition, the FE-SEM stage can be coordinated to the target position in the low-magnification (LM) image which is observed with the light microscope. Subsequently the field of view (FOV) in a FE-SEM can move to any region of interest in the LM image and the same FOV can be observed in the FE-SEM under the MirrorCLEM system. Also, the system is capable of displaying an overlay of the light microscope and FE-SEM images in real time. The Hitachi SU8220 FE-SEM equipped with the MirrorCLEM system has already been used to clarify the ultrastructure of peroxisomes containing GFP in the cotyledon and root in transgenic Arabidopsis thaliana .
Hitachi High-Tech will launch MirrorCLEM as a CLEM system option for the SU8200 series of FE-SEMs, with sales projected at 50 sets per year. Moving forward, this will maximize and enhance FE-SEM capabilities, and can be interfaced with numerous microscopes, to contribute to the advancement of CLEM analysis in a variety of fields including medical and life sciences.
Note:
1. Organelle: A term of specialized structure within the cell that has specialized function
2. Green fluorescent protein: A fluorescent protein that emits a green light when irradiated with excitation light of appropriate wavelengths
About Hitachi High-Technologies Corporation
Hitachi High-Technologies Corporation, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including Science & Medical Systems, Electronic Device Systems, Industrial Systems, and Advanced Industrial Products. The company's consolidated sales for FY 2015 were approx. JPY629 billion [USD5.8 billion].
For further information, visit http://www.hitachi-hightech.com/global/ .
About RIKEN
RIKEN is Japan's largest research institute for basic and applied research. Over 2500 papers by RIKEN researchers are published every year in leading scientific and technology journals covering a broad spectrum of disciplines including physics, chemistry, biology, engineering, and medical science. RIKEN's research environment and strong emphasis on interdisciplinary collaboration and globalization has earned a worldwide reputation for scientific excellence.
For further information, visit Website: www.riken.jp/en/
Facebook: www.facebook.com/RIKEN.english
Twitter: @riken_en
View source version on businesswire.com: http://www.businesswire.com/news/home/20160721005682/en/
Contact:
Hitachi High-Technologies Corporation,
Marketing Dept., Science
Systems Sales & Marketing Div.,
Science & Medical Systems
Business Group
Shigeaki Tachibana, Kenichi Sato
customercenter2.ev@hitachi-hightech.com
or
RIKEN
Center for Sustainable Resource Science,
Mass Spectrometry and
Microscopy Unit, Technology Platform Division,
Kiminori Toyooka
toyooka@riken.jp
or
For
Media Inquiries
Hitachi High-Technologies Corporation,
CSR
& Corporate Communications Dept.,CSR Div.,
Shota Sano, Aiko
Matsumoto
shota.sano.wv@hitachi-hightech.com
or
RIKEN
Global Communications
Jens Wilkinson, +81-(0)48-462-1225
pr@riken.jp
http://www.riken.jp/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release
Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release
Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma
Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release
Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized
DEWA Announces Record Quarterly Revenue of AED 5.96 Billion and Quarterly Cash from Operations of AED 3.85 Billion12.5.2025 17:06:00 CEST | Press release
Dubai Electricity and Water Authority PJSC (ISIN: AED001801011) (Symbol: DEWA), the Emirate of Dubai’s exclusive electricity and water services provider, listed on the Dubai Financial Market (DFM), reported its first quarter 2025 consolidated financial results, recording quarterly revenue of AED 5.96 billion, EBITDA of AED 2.43 billion, operating profit of AED 838 million and net profit of AED 496 million. The company also generated a record net cash from operations of AED 3.85 billion resulting in closing cash and cash equivalents of AED 8.17 billion, which is AED 2.07 billion higher than the balance as at year-end 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512715455/en/ Dubai Electricity and Water Authority announces record quarterly revenue of AED 5.96 billion and quarterly Cash from Operations of AED 3.85 billion (English Graphic: AETOSWire) “We are progressing in our journey to Net Zero by 2050 and will con
Alisher Usmanov Wins Legal Case Against Luxembourg’s Largest Media Group, Says Law Firm Rechtsanwälte Steinhöfel12.5.2025 14:43:00 CEST | Press release
A German court has banned Mediahuis Luxembourg S.A., the most important media holding in Luxembourg, from referring to Alisher Usmanov as the owner of the yacht Dilbar. Mediahuis Luxembourg is the leading publishing company in Luxembourg, with such assets as newspapers and online platforms, including Luxemburger Wort, Luxembourg Times and others. On May 5, 2025, the Regional Court of Hamburg ruled that the following statement published by Luxembourg Times was false and prohibited its further publication: “The luxury yacht Dilbar was seized in Hamburg’s harbour in 2022 following Russia’s invasion under EU sanctions. The yacht is owned through a company and trust by Uzbek-Russian billionaire Alisher Usmanov.” The court found the statement to be in violation of Mr. Usmanov’s rights and prohibited its distribution. In the event of non-compliance with the prohibition, Mediahuis may be fined up to €250,000 for each individual offense. Moreover, if such a fine is not enforceable, it may be re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom